Edition:
India

Profile: Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

44.80PLN
23 Apr 2019
Change (% chg)

0.80zł (+1.82%)
Prev Close
44.00zł
Open
45.95zł
Day's High
45.95zł
Day's Low
44.50zł
Volume
6,111
Avg. Vol
18,964
52-wk High
51.10zł
52-wk Low
28.10zł

Celon Pharma SA is a Poland-based company primarily engaged in the pharmaceuticals manufacture. The Company focuses on research, development and production of generic drugs for cancer, neurological diseases, diabetes and other metabolic disorders treatment, among others. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir and Valzek, as well as inhalation powder, such as Salmex. The Company's research center develops pharmaceuticals within a number of therapeutic areas, including oncology, neurology, as well as inflammatory and metabolic diseases. The Company is a subsidiary of Glatton sp z o o.

Company Address

Celon Pharma SA

Ogrodowa 2A, Kielpin
    05-092
P: +4822.7515933
F: +4822.7514458

Company Web Links